Comparison of the Effectiveness of Minoxidil, Cetirizine 1% and Diclofenac 3% in treatment of androgenic alopecia

Comparison of the effectiveness of Minoxidil 5% solution, Cetirizine 1% solution and Diclofenac 3% solution in treatment of androgenic alopecia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190511043547N1

Enrollment

Registered

2019-12-16

Start date

2019-07-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

androgenetic alopecia. androgenic alopecia

Interventions

Intervention 1: Cetirizine 1% solution made by the Shahid Beheshti faculty of pharmacy,1cc twice daily topicaly on the scalp. Intervention 2: Diclofenac 3% solution made by the Shahid Beheshti facul

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 18-60 years old men with androgenetic alopecia No contraindication for topical trreatment

Exclusion criteria

Exclusion criteria: systemic disease use of other drug in treatment of androgenic alopecia other pattern of hair loss

Design outcomes

Primary

Measure	Time frame
Severity of hair loss. Timepoint: 0,after 2 and 4 months. Method of measurement: fotofinder.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNamazi Nastaran

Shahid Beheshti University of Medical Sciences

nastaran.namazi.md@gmail.com+98 21 25719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026